Search bioRxiv⌕ Search

Biology subjects

Senguttuvan, V.

Publications and source records attributed to Senguttuvan, V..

3 recordsLinked to original sources

Inferring Protein Variant Impacts Across Contexts

Multiplexed assays of variant effects (MAVEs) measure the functional impact of many protein sequence variants in parallel, potentially covering all possible single amino acid substitutions. Unlike current computational variant effect predictors, MAVEs can reveal the effects of variants under different genetic and environmental contexts. However, whereas the space of possible contexts is effectively infinite, contextual MAVE studies are limited by finite experimental budgets. To maximize coverage across contexts, one strategy is to carry out sub-saturation contextual MAVEs and then fill in the gaps via imputation. Here, we categorize and compare different imputation challenges, explore a collection of multi-context imputation solutions, including linear mixed-effects models, random forests, and autoencoders, and provide insight into how best to proceed for a given imputation task. We find that the optimal method depends on the imputation task and how densely the contexts have been measured. More flexible models excel when measurements are plentiful, whereas the simplest models prove most reliable when measurements are sparse. However, the simple source-to-target regression models, although well suited to imputing scores for variants measured in the source context, cannot impute scores for variants that were not measured in either context. This is a major limitation when both maps are sparsely measured. We provide a conceptual framework and an initial evaluation of multi-context imputation methods that can extend the scope of large-scale studies of context-dependent variant effects.

genetics↗

Environment-dependent landscapes of coding variant impacts on coproporphyrinogen oxidase

Hereditary coproporphyria (HCP) -- caused by variants in coproporphyrinogen oxidase (CPOX) -- can be diagnosed via genome sequencing. However, 74% of clinically-reported CPOX missense variants are classified as variants of uncertain significance (VUS) due to lack of evidence. CPOX variant classification is further complicated by environment-dependence: For example, the CPOX variant p.Asn272His (c.814A>C) is classified as benign yet has been associated with HCP-like symptoms in the context of mercury exposure. Here we measured the functional impact of nearly all possible CPOX amino acid substitutions in both the presence and absence of mercury. The resulting CPOX variant effect maps reflect known protein structure and mutational tolerance patterns while also offering new sequence-structure-function insights. Scores from this atlas not only distinguish pathogenic from benign variants but also identify mercury-dependent variant impacts, thus informing our clinical, structural, and functional understanding of CPOX deficiency and illustrating the value of systematic context-dependent multiplexed assays of genetic variant effects.

molecular biology↗

Landscapes of missense variant impact for human superoxide dismutase 1

Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease for which important subtypes are caused by variation in the Superoxide Dismutase 1 gene SOD1. Diagnosis based on SOD1 sequencing can not only be definitive but also indicate specific therapies available for SOD1-associated ALS (SOD1-ALS). Unfortunately, SOD1-ALS diagnosis is limited by the fact that a substantial fraction (currently 26%) of ClinVar SOD1 missense variants are classified as "variants of uncertain significance" (VUS). Although functional assays can provide strong evidence for clinical variant interpretation, SOD1 assay validation is challenging, given the current incomplete and controversial understanding of SOD1-ALS disease mechanism. Using saturation mutagenesis and multiplexed cell-based assays, we measured the functional impact of over two thousand SOD1 amino acid substitutions on both enzymatic function and protein abundance. The resulting missense variant effect maps not only reflect prior biochemical knowledge of SOD1 but also provide sequence-structure-function insights. Importantly, our variant abundance assay can discriminate pathogenic missense variation and provides new evidence for 41% of missense variants that had been previously reported as VUS, offering the potential to identify additional patients who would benefit from therapy approved for SOD1-ALS.

genetics↗